Cluster headaches originate from a malfunction deep in the brain, specifically in a small region called the hypothalamus. Unlike tension headaches or migraines, which have a range of diffuse triggers, cluster headaches are driven by a distinct neurological mechanism that hijacks the brain’s internal clock and pain-signaling pathways. Understanding what sets this process in motion helps explain the condition’s unusual patterns: why attacks strike at the same time each day, why they come in seasonal bouts, and why certain substances can trigger an attack within minutes.
The Hypothalamus as the Starting Point
The hypothalamus is a small structure near the center of the brain that regulates sleep-wake cycles, hormone release, and body temperature. Brain imaging studies have shown that during a cluster headache attack, a specific area called the posterior hypothalamic grey matter activates on the same side as the pain. This activation appears only during an active attack. Patients scanned between bouts, when they were pain-free, showed no hypothalamic activation at all.
This finding was pivotal because it identified cluster headache as fundamentally a brain disorder, not simply a blood vessel problem. The hypothalamus appears to be the initial trigger, the “first mover” that kicks off a cascade of nerve signaling and vascular changes responsible for the pain and its accompanying symptoms. Researchers now classify cluster headache as a neurovascular condition, meaning both the nervous system and blood vessels play essential roles.
How the Pain Signal Travels
Once the hypothalamus fires, it activates the trigeminovascular system, a network of nerve fibers that carries pain signals from the face and head. The trigeminal nerve, the largest cranial nerve, has branches that supply sensation to the eye socket, forehead, and temple, which is exactly where cluster headache pain concentrates.
When trigeminal nerve fibers activate, they release a powerful signaling molecule called CGRP (calcitonin gene-related peptide) that dilates blood vessels around the brain and triggers inflammation. During an attack, CGRP levels rise sharply in the blood draining from the affected side of the head. This isn’t just a byproduct of the pain. Injecting CGRP into a cluster headache patient during an active bout will reliably trigger a full attack, confirming its central role in the process.
Trigeminal activation also sets off what’s called the trigeminoparasympathetic reflex. This is a loop between the pain-sensing trigeminal nerve and the parasympathetic nerves that control things like tear production, nasal congestion, and blood flow to the face. That reflex is why cluster headaches come with such distinctive autonomic symptoms: a red, watering eye, a drooping eyelid, a stuffy or runny nostril, and facial sweating, all on the same side as the pain. In cluster headache, this reflex appears to be abnormally disinhibited, meaning the brain’s normal braking mechanism on the reflex isn’t working properly.
Why Attacks Follow a Clock
One of the most striking features of cluster headache is its clockwork timing. Attacks often hit at the same hour each day, frequently in the early morning hours, and cluster periods themselves tend to recur in the same season year after year. This pattern points directly to the body’s circadian system.
The brain’s master clock, the suprachiasmatic nucleus, sits in the front part of the hypothalamus. It calibrates itself to light exposure and synchronizes biological rhythms throughout the body. It connects to the pineal gland (which produces melatonin), to areas controlling the autonomic nervous system, and to hormone-releasing structures in the brain. In people with cluster headache, multiple parts of this circadian machinery show measurable abnormalities.
Melatonin levels, widely considered a reliable marker of circadian function, are consistently lower in cluster headache patients compared to healthy controls. Levels of other signaling molecules tied to the master clock are also altered. Perhaps most telling, researchers have found changes in the expression of core circadian genes, specifically in a gene called Rev-ERB-alpha, which plays a key role in the molecular feedback loop that keeps the body’s clock running on time. These aren’t changes that occur only during attacks. They represent a baseline difference in how the circadian system is wired in people who get cluster headaches.
The Role of Genetics
Cluster headache runs in families more often than you might expect. Across large studies, roughly 1 in 12 people with cluster headache report a family member with the same condition, and some estimates put the rate as high as 1 in 5. When researchers mapped out family trees, about 73% of hereditary cases followed a dominant inheritance pattern, meaning a single copy of the relevant gene variant from one parent could be enough to increase risk.
Several genes have been identified as possible contributors. These include genes involved in the sleep-wake neuropeptide orexin (its receptor gene, HCRTR2), alcohol metabolism (ADH4), and signaling pathways connected to the autonomic nervous system. No single gene causes cluster headache on its own. The current understanding is that multiple genetic variants each add a small amount of risk, and environmental factors determine whether that genetic predisposition ever becomes active disease.
Triggers During an Active Cycle
An important distinction with cluster headaches is that most triggers only work during an active cluster period. Outside of a bout, the same substances have no effect.
Alcohol is the most commonly reported trigger. Even small amounts can provoke an attack within minutes to an hour during a cluster period. The mechanism involves vasodilation: alcohol expands blood vessels, which in an already-sensitized trigeminovascular system is enough to set off a full attack. Nitroglycerin, a medication that also dilates blood vessels, reliably triggers attacks in the same way and is used in research settings to study the condition. Histamine, another vasodilator, can do the same.
There is also evidence that inflammation in the cavernous sinus, a collection of veins behind the eye, plays a secondary role. This inflammation may compress sympathetic nerve fibers that travel through the area, contributing to the drooping eyelid and constricted pupil that often accompany attacks. Vasodilating substances may worsen this process by increasing the blood volume flowing through an already-compromised venous space.
Smoking and Cluster Headache
The link between cigarette smoking and cluster headache is unusually strong compared to other headache disorders. In a study of 250 cluster headache patients, 61% were current or former smokers. Toxic chemicals in cigarette smoke may alter neurotransmitter function in the hypothalamus, potentially triggering the condition in people who are genetically susceptible. Some research suggests that even secondhand smoke exposure during childhood may increase the risk of developing cluster headache later in life.
That said, quitting smoking does not reliably stop cluster headaches once they’ve started. And nearly 40% of patients in that same study had never smoked at all. Smoking appears to be a risk factor for developing the condition rather than a direct trigger for individual attacks.
Who Gets Cluster Headaches
Cluster headache affects roughly 1 in 500 people. It has historically been considered a predominantly male condition, with older studies reporting a male-to-female ratio of 6 to 1. That gap has narrowed considerably in recent decades, with current estimates placing the ratio between 2.5 to 1 and 5 to 1. The shift likely reflects better recognition and diagnosis in women rather than a true change in who gets the condition.
Attacks typically begin between the ages of 20 and 40. A single attack lasts between 15 minutes and 3 hours without treatment, and attacks can occur anywhere from once every other day to eight times in a single day. They cluster into bouts lasting weeks to months, often separated by remission periods of months or years. About 10 to 15% of patients have the chronic form, where remission periods either don’t occur or last less than three months.
What Makes It Different From Other Headaches
The combination of severe one-sided pain around the eye, autonomic symptoms on the same side, and intense restlessness or agitation sets cluster headache apart from virtually every other headache type. People with migraines typically want to lie still in a dark room. People mid-cluster attack often pace, rock, or bang their heads against a wall because the pain is so intense that staying still feels impossible.
The International Headache Society requires at least five attacks with specific features for a formal diagnosis: severe unilateral pain in or around the eye lasting 15 to 180 minutes, at least one same-side autonomic symptom (tearing, nasal congestion, eyelid swelling, facial sweating, or a constricted pupil and drooping lid), and a sense of restlessness or agitation. Recognizing this pattern is important because cluster headache is frequently misdiagnosed as migraine or sinus headache, delaying effective treatment by an average of several years.